Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations

Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations

Malaria remains a major cause of morbidity and mortality in Africa, particularly in children under five years of age. Availability of effective anti-malarial drug treatment is a cornerstone for malaria control and eventual malaria elimination. Artemisinin-based combination therapy (ACT) is worldwide...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Tindana, P, de Haan, F, Amaratunga, C, Dhorda, M, van der Pluijm, RW, Dondorp, AM, Cheah, PY
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	BioMed Central 2021

Eitemau Tebyg

Triple artemisinin-based combination therapies for malaria – a new paradigm?
gan: van der Pluijm, RW, et al.
Cyhoeddwyd: (2020)

Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: An analysis of stakeholders’ perspectives in Burkina Faso and Nigeria
gan: Paulina Tindana, et al.
Cyhoeddwyd: (2022-01-01)

Expert perspectives on the introduction of Triple Artemisinin-based Combination Therapies (TACTs) in Southeast Asia: a Delphi study
gan: Freek de Haan, et al.
Cyhoeddwyd: (2022-04-01)

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
gan: van der Pluijm, RW, et al.
Cyhoeddwyd: (2022)

Investigating the efficacy of triple artemisinin-based combination therapies (TACTs) for treating Plasmodium falciparum malaria patients using mathematical modelling
gan: Dini, S, et al.
Cyhoeddwyd: (2018)

Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
gan: Emmanuel Kokori, et al.
Cyhoeddwyd: (2024-01-01)

Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion
gan: Freek de Haan, et al.
Cyhoeddwyd: (2023-09-01)

Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
gan: Nguyen, TD, et al.
Cyhoeddwyd: (2023)

To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?
gan: Freek de Haan, et al.
Cyhoeddwyd: (2021-01-01)

Modulation of triple artemisinin-based combination therapy pharmacodynamics by Plasmodium falciparum genotype
gan: Ansbro, MR, et al.
Cyhoeddwyd: (2020)

Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam
gan: Van Anh Thi Cao, et al.
Cyhoeddwyd: (2023-10-01)

Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
gan: Tran Dang Nguyen, et al.
Cyhoeddwyd: (2023-07-01)

The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso
gan: Rosemonde M. Guissou, et al.
Cyhoeddwyd: (2023-09-01)

Everyday Aesthetic Practices, Ethics and Tact
gan: Ossi Naukkarinen
Cyhoeddwyd: (2014-06-01)

Artemisinin-resistant malaria in Africa demands urgent action
gan: Dhorda, M, et al.
Cyhoeddwyd: (2024)

Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
gan: Miotto, O, et al.
Cyhoeddwyd: (2020)

Artemisinin resistance in falciparum malaria
gan: Dondorp, A
Cyhoeddwyd: (2012)

Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
gan: Peto, TJ, et al.
Cyhoeddwyd: (2022)

Experiences, perceptions and ethical considerations of the malaria infection study in Thailand
gan: Naemiratch, B, et al.
Cyhoeddwyd: (2025)

Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response
gan: Zhu, L, et al.
Cyhoeddwyd: (2022)

Are national treatment guidelines for falciparum malaria in line with WHO recommendations and is antimalarial resistance taken into consideration? – A review of guidelines in non-endemic countries
gan: Visser, MT, et al.
Cyhoeddwyd: (2022)

TACT Design
gan: John Bradley
Cyhoeddwyd: (1996-05-01)

Spread of artemisinin resistance in Plasmodium falciparum malaria.
gan: Ashley, E, et al.
Cyhoeddwyd: (2014)

Artemisinin Resistance in Plasmodium falciparum Malaria REPLY
gan: Dondorp, A, et al.
Cyhoeddwyd: (2009)

Antimalarial mass drug administration: ethical considerations
gan: Cheah, PY, et al.
Cyhoeddwyd: (2016)

Effectiveness and safety of 3 and 5 day courses of artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar
gan: Tun, KM, et al.
Cyhoeddwyd: (2018)

The threat of artemisinin-resistant malaria.
gan: Dondorp, A, et al.
Cyhoeddwyd: (2011)

Artemisinin resistance and stage dependency of parasite clearance in Falciparum malaria
gan: Intharabut, B, et al.
Cyhoeddwyd: (2019)

The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background
gan: Zhu, L, et al.
Cyhoeddwyd: (2018)

The mechanism of artemisinin resistance of Plasmodium falciparum malaria parasites originates in their initial transcriptional response
gan: Zhu, L, et al.
Cyhoeddwyd: (2021)

The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background
gan: Zhu, Lei, et al.
Cyhoeddwyd: (2019)

The digital geographies of tact
gan: Mike Duggan
Cyhoeddwyd: (2024-12-01)

How to contain artemisinin- and multidrug-resistant Falciparum malaria
gan: Dondorp, A, et al.
Cyhoeddwyd: (2017)

Avec tact et délicatesse...
gan: Yvelyne Fumat
Cyhoeddwyd: (2001-01-01)

Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance
gan: Mok, S., et al.
Cyhoeddwyd: (2016)

Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response
gan: Zhu, Lei, et al.
Cyhoeddwyd: (2022)

Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response
gan: Lei Zhu, et al.
Cyhoeddwyd: (2022-03-01)

Artemisinin resistance in Plasmodium falciparum malaria.
gan: Dondorp, A, et al.
Cyhoeddwyd: (2009)

Genomic epidemiology of artemisinin resistant malaria.
gan: MalariaGEN Plasmodium falciparum Community Project, et al.
Cyhoeddwyd: (2016)

Spread of artemisinin resistance in plasmodium falciparum malaria
gan: Tripura, Rupam, et al.
Cyhoeddwyd: (2015)